Xilio Therapeutics

XLONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$59.485 M

$9.04 +0.22%

Close of 22 Sept 2026

Revenue

$43.8M

#2775 by revenue

Earnings

-$35.0M

Loss-making

Shares outstanding

5,782,511

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#345TalpheraTLPH$60.7M
#346Zhengye BiotechnologyZYBT$60.7M
#347Xilio TherapeuticsXLO$59.5M
#348Serina TherapeuticsSER$58.7M
#349Impact BiomedicalIBO$56.9M

What if Xilio Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$4,594,724

Per share 508,266× higher

Bitcoin $1.74T

$264,683.22

Per share 29,279× higher

Nvidia $5.52T

$838,243.48

Per share 92,726× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Xilio Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.